Ensuring Access to Essential Drugs Act
3/21/2025, 6:28 PMSummary of Bill HR 1922
Bill 119 HR 1922, also known as the "Medicare Part D Manufacturer Discount Exemption Act," aims to make changes to the Medicare program under Title XVIII of the Social Security Act. Specifically, this bill seeks to exempt certain drugs from the Part D manufacturer discount program.The Part D manufacturer discount program was established to provide discounts on prescription drugs to Medicare beneficiaries. However, some drugs are currently required to participate in this program, which can limit access to certain medications for patients.
If passed, Bill 119 HR 1922 would allow certain drugs to be exempt from the Part D manufacturer discount program. This exemption would provide more flexibility for manufacturers and potentially increase access to a wider range of medications for Medicare beneficiaries. Overall, this bill addresses concerns about access to prescription drugs for Medicare beneficiaries and aims to improve the efficiency and effectiveness of the Medicare program. It will be important to monitor the progress of this bill as it moves through the legislative process to see how it may impact Medicare beneficiaries and the healthcare system as a whole.
Read the Full Bill
Current Status of Bill HR 1922
Bill HR 1922 is currently in the status of Bill Introduced since March 6, 2025. Bill HR 1922 was introduced during Congress 119 and was introduced to the House on March 6, 2025. Bill HR 1922's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 6, 2025Bipartisan Support of Bill HR 1922
Total Number of Sponsors
3Democrat Sponsors
0Republican Sponsors
3Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
1Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1922
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 1922
To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.Comments
Most relevant
Sponsors and Cosponsors of HR 1922
Latest Bills
Veterans 2nd Amendment Protection Act of 2025
Bill S 478March 24, 2025
Montgomery GI Bill Selected Reserves Tuition Fairness Act of 2025
Bill HR 983March 24, 2025
Disaster Related Extension of Deadlines Act
Bill HR 1491March 24, 2025
Filing Relief for Natural Disasters Act
Bill HR 517March 24, 2025
IMPACT Act
Bill HR 1534March 24, 2025
RESTORE Act
Bill HR 1704March 24, 2025
Hatch Act Enforcement Transparency and Accountability Act
Bill HR 1688March 24, 2025
HOPE for Homeownership Act
Bill HR 1745March 24, 2025
Protecting Americans’ Social Security Data Act
Bill HR 1877March 24, 2025
Precision Agriculture Satellite Connectivity Act
Bill HR 1618March 24, 2025